Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas

Alberto Martin, Philip D. Bardwell, Caroline J. Woo, Manxia Fan, Marc J. Shulman, Matthew D. Scharff

Research output: Contribution to journalArticle

221 Scopus citations

Abstract

The production of high-affinity protective antibodies requires somatic hypermutation (SHM) of the antibody variable (V)-region genes. SHM is characterized by a high frequency of point mutations that occur only during the centroblast stage of B-cell differentiation. Activation-induced cytidine deaminase (AID), which is expressed specifically in germinal-centre centroblasts, is required for this process, but its exact role is unknown. Here we show that AID is required for SHM in the centroblast-like Ramos cells, and that expression of AID is sufficient to induce SHM in hybridoma cells, which represent a later stage of B-cell differentiation that does not normally undergo SHM. In one hybridoma, mutations were exclusively in G-C base pairs that were mostly within RGYW or WRCY motifs, suggesting that AID has primary responsibility for mutations at these nucleotides. The activation of SHM in hybridomas indicates that AID does not require other centroblast-specific cofactors to induce SHM, suggesting either that it functions alone or that the factors it requires are expressed at other stages of B-cell differentiation.

Original languageEnglish (US)
Pages (from-to)802-806
Number of pages5
JournalNature
Volume415
Issue number6873
DOIs
StatePublished - Feb 14 2002

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas'. Together they form a unique fingerprint.

  • Cite this

    Martin, A., Bardwell, P. D., Woo, C. J., Fan, M., Shulman, M. J., & Scharff, M. D. (2002). Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature, 415(6873), 802-806. https://doi.org/10.1038/nature714